Silence Therapeutics (SLN) Leases (2023 - 2025)
Silence Therapeutics (SLN) has disclosed Leases for 3 consecutive years, with $167000.0 as the latest value for Q4 2025.
- Quarterly Leases rose 6.37% to $167000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $167000.0 through Dec 2025, up 6.37% year-over-year, with the annual reading at $167000.0 for FY2025, 6.37% up from the prior year.
- Leases hit $167000.0 in Q4 2025 for Silence Therapeutics, down from $192000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $370000.0 in Q4 2023 to a low of $58000.0 in Q2 2025.
- Historically, Leases has averaged $175166.7 across 3 years, with a median of $162000.0 in 2024.
- Biggest five-year swings in Leases: tumbled 57.57% in 2024 and later grew 6.37% in 2025.
- Year by year, Leases stood at $370000.0 in 2023, then crashed by 57.57% to $157000.0 in 2024, then increased by 6.37% to $167000.0 in 2025.
- Business Quant data shows Leases for SLN at $167000.0 in Q4 2025, $192000.0 in Q3 2025, and $58000.0 in Q2 2025.